SCHEMBL18999980

SCHEMBL18999980

Cc1nc(C(C)C)c(C(C)C)c(C(C)C)c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13054402 0.85
SCHEMBL12795957 0.80 KDM5B (0.31)
SCHEMBL12795954 0.80 KDM5B (0.31)
SCHEMBL10093818 0.78 KDM5B (0.31)
SCHEMBL25467513 0.75
SCHEMBL12398683 0.75 KDM5B (0.31)
SCHEMBL27455610 0.74 HTT (0.37)
SCHEMBL2600739 0.74 GCGR (0.30)
SCHEMBL12795977 0.72 GCGR (0.33)
SCHEMBL13438489 0.72 KDM4E (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017106607-A1 POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed
US-20170174653-A1 TLR7/8 ANTAGONISTS AND USES THEREOF MERCK PATENT GMBH (DE) 2017-06-22 US disclosed